I’ve previously written about fellow Floridian Kayla Mack, a woman in her 50s who has Type 3 von…
Jennifer Lynne
Jennifer Lynne was diagnosed with hemophilia B and von Willebrand disease during childhood. A marketing and journalism graduate of the University of Wisconsin–Madison, she is the founder of GirlsBleedToo.com, a platform dedicated to raising awareness about bleeding disorders in women and girls. Through her column, she shares personal experiences to educate, advocate, and amplify the voices of women in the bleeding disorders community. All opinions expressed are her own and do not reflect those of her clients or affiliated organizations.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Jennifer Lynne
Dear 11-year-old me, Life might feel overwhelming at this moment, but remember, you are stronger than you realize.
I’d enjoyed several months without any bleeding problems until I experienced an unexpected ankle bleed last week. The elevator…
Nearly a year has passed since Hurricane Ian wreaked havoc on southwest Florida, leaving my hometown of Punta Gorda…
Last week, I stumbled upon the Tour de France while aimlessly flipping through TV channels. This annual professional…
When dealing with health issues, does when you were born matter? For those living with hemophilia, the answer is…
The pain that accompanied my periods was excruciating, exacerbated by my two bleeding disorders, hemophilia B and von…
I rarely disclose my diagnosis of hemophilia B and von Willebrand disease to others. I don’t like…
Clinical trials for hemophilia are essential to advance medical knowledge and develop treatments. But for decades, trials related…
Note: This column describes the author’s own experiences with Mounjaro (tirzepatide). Not everyone will have the same response to…